Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Most Popular Stories

New contenders will duke it out with Vertex for the hep C crown
Mylan snags Pfizer's Advair copy, inhaler technology
Biotech spin-out grabs $76M in venture cash for antibiotic work
Pharmacies accuse Pfizer, Ranbaxy of secret Lipitor deal
Bavarian Nordic sees positive results in small therapeutic cancer vax study
Class-action securities suit goes forward against Amgen

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Director, IT Global Operation Services, End-User Informatics Job
Celgene Corporation - Summit, NJ, US
Partner
Lundbeckfond Ventures - Copenhagen, Denmark
Associate Director, Global Production Planning & Inventory Control Job
Celgene Corporation - Basking Ridge, NJ, US
Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US
Clinical Research Coordinator
Lovelace Respiratory Research Institute - Albuquerque, NM

More Jobs >>

Events

CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami
Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia
New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
Just Released: New Trends in Preventive and Therapeutic Vaccine

More Events >>

HIV/AIDS

Thai HIV vax trial controversy continues to brew
October 15, 2009
AIDS vax a surprising success in big trial
September 23, 2009
Bioengineered plant makes antibodies against HIV
May 20, 2009
Businessman donates $100M to HIV vaccine institute
February 4, 2009
World AIDS day marked by new vaccine progress
December 4, 2008
T-cell HIV vax still promising
November 12, 2008
HIV vax debacle linked to T-cell activation
November 6, 2008
Nobel winners frustrated, hopeful about AIDS vax
October 9, 2008
VGX Pharma gets $23M NIH grant for HIV vax
October 6, 2008
Scripps wins $30M for HIV research center
October 2, 2008
Woman's immune system may be key to HIV vax
August 14, 2008
IAVI maps out a new route to AIDS vaccine
August 7, 2008
Fauci says HIV vaccine requires a new approach
July 31, 2008
Human protective system disables HIV vaccines
December 20, 2007

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

Home | Subscribe | Advertise | Mobile Edition | RSS | Privacy | Site Map | Editors | List in Marketplace | Supplier in Marketplace

THE FIERCEMARKETS NETWORK

FierceEnergy | FierceSmartGrid | FierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceHealthPayer | FiercePracticeManagement | FierceEMR | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceGovernment | FierceHomelandSecurity | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceMedicalDevices | FierceDrugDelivery | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceEnterpriseCommunications | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe | FierceCable

© 2011 FierceMarkets. All rights reserved.